Elevance Health
ELV
1,656 hedge funds and large institutions have $99.5B invested in Elevance Health in 2023 Q4 according to their latest regulatory filings, with 240 funds opening new positions, 596 increasing their positions, 594 reducing their positions, and 85 closing their positions.
182% more first-time investments, than exits
New positions opened: 240 | Existing positions closed: 85
10% more call options, than puts
Call options by funds: $821M | Put options by funds: $744M
9% more capital invested
Capital invested by funds: $90.8B → $99.5B (+$8.62B)
9% more funds holding
Funds holding: 1,524 → 1,656 (+132)
1.62% more ownership
Funds ownership: 88.15% → 89.78% (+1.6%)
0% more repeat investments, than reductions
Existing positions increased: 596 | Existing positions reduced: 594
11% less funds holding in top 10
Funds holding in top 10: 55 → 49 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.4B |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$458M |
| 3 |
Man Group
London,
United Kingdom
|
+$292M |
| 4 |
BlackRock
New York
|
+$248M |
| 5 |
MIS
Morningstar Investment Services
Chicago,
Illinois
|
+$236M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$387M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$316M |
| 3 |
Two Sigma Advisers
New York
|
-$230M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$166M |
| 5 |
Two Sigma Investments
New York
|
-$164M |
ELV Hedge Fund Activity: Q4 2023 in Review
1,656 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q4 2023, worth a combined $99.5B — up 9.5% from $90.8B a quarter earlier.
Buyers outnumbered sellers: 240 funds opened new ELV positions and 85 closed out — a net gain of 155 holders — while 596 added to existing stakes and 594 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.4B. The largest seller was Putnam Investments, cutting an estimated $387M.
- 1,656 institutional investors held Elevance Health (ELV) as of Q4 2023, up from 1,524 in Q3 2023.
- Funds reported $99.5B of Elevance Health stock for Q4 2023, up 9.5% quarter-over-quarter.
- 240 funds opened new Elevance Health positions in Q4 2023 and 85 closed out, a net change of +155 holders.
- The largest Elevance Health buyer in Q4 2023 was Morgan Stanley, an estimated $1.4B added.
- The largest Elevance Health seller in Q4 2023 was Putnam Investments, an estimated $387M sold.
Based on aggregated 13F filings for Q4 2023.